RTMTX
Price
$87.17
Change
-$0.01 (-0.01%)
Updated
Nov 13 closing price
VTSAX
Price
$144.14
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

RTMTX vs VTSAX

Header iconRTMTX vs VTSAX Comparison
Open Charts RTMTX vs VTSAXBanner chart's image
Russell Inv Tax-Managed US Large Cap M
Price$87.17
Change-$0.01 (-0.01%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$144.14
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
RTMTX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RTMTX vs. VTSAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RTMTX is a StrongBuy and VTSAX is a Buy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.73T vs. RTMTX (9.88B). VTSAX pays higher dividends than RTMTX: VTSAX (1.35) vs RTMTX (0.57). RTMTX was incepted earlier than VTSAX: RTMTX (8 years) vs VTSAX (24 years). RTMTX is a more actively managed with annual turnover of: 25.00 vs. VTSAX (2.00). RTMTX has a lower initial minimum investment than VTSAX: RTMTX (0) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 33.39 vs. RTMTX (31.59). VTSAX (87.46) and RTMTX (86.56) have equivalent 5 years return.
RTMTXVTSAXRTMTX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years24 years-
Gain YTD23.80324.89196%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets9.88B1.73T1%
Annual Yield % from dividends0.571.3542%
Returns for 1 year31.5933.3995%
Returns for 3 years24.8022.82109%
Returns for 5 years86.5687.4699%
Returns for 10 yearsN/A194.07-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX50.580.83
+1.67%
Vertex
IT551.801.14
+0.21%
Gartner
PDFS31.88-0.95
-2.89%
PDF Solutions
KMDA6.06-0.21
-3.35%
Kamada Ltd
VRCA0.84-0.08
-8.37%
Verrica Pharmaceuticals